期刊文献+

粪便隐血试验在大肠癌诊断中的应用及意义评定

Application of Stool Occult Blood Test in Diagnosing Large Intestinal Carcinoma,and the Ealuation on its Significance
原文传递
导出
摘要 为研究探讨粪便隐血试验在大肠癌诊断中的应用意义,2015年1月至2017年12月,选择就诊于我院的120例疑似大肠癌患者,对患者实施粪便隐血试验,以内镜病理诊断结果为参照,计算粪便隐血试验对大肠癌的诊断灵敏度、特异度、准确率,并采用一致性检验方法,分析粪便隐血试验与内镜病理诊断结果的一致性。结果显示,120例疑似大肠癌患者中,经内镜病理诊断,共确诊86例。以内镜病理诊断结果为参照,粪便隐血试验对大肠癌的诊断灵敏度、特异度、准确率分别为96.51%、97.06%、96.67%。经一致性检验分析,粪便隐血试验与内镜病理诊断结果的一致性系数Kappa值>0.7,诊断结果之间一致性良好。结果表明,采用粪便隐血试验可对大肠癌予以灵敏、准确检出,可作为大肠癌的初步筛查手段。 In order to investigate the application significance of stool occult blood test(SOBT) used in diagnosis of large intestinal carcinoma(LIC), 120 suspected LIC patients, who were admitted in author's hospital from Jan. 2015 to Dec. 2017,were selected to carry out SOBT.Contrasted to the results of endoscopic pathological diagnosis(EPD), the sensitivity, specificity, and accuracy rate of SOBT for LIC were calulated,and the consistency between SOBT and EPD were analysed by using consistency test.As results,86 of 120 suspected LIC patients were confirmed by EPD.Conirast to which the sensitivity, specificity, and accuracy rate of SOBT for LIC were respectively 96.51%,97.06% and 96.67%.By consistency analysis, between SOBT and EPO,the consistency coefficient kappa value was 〉0.7 ,so there was good consistency between both diagnosis results.Results show that SOBT for inspecting LIC is sensitive and assuracy,and could be used as preliminary screening method for LIC.
作者 缐淑芳 时强
出处 《中国肛肠病杂志》 2018年第7期12-13,共2页 Chinese Journal of Coloproctology
关键词 大肠癌 诊断 粪便隐血试验 Large intestinal carcinoma Diagnosis Stool occult blood test accuracy between between could be
  • 相关文献

参考文献7

二级参考文献69

  • 1顾勇,段炜,吴秀华,何丽红.消化系统恶性肿瘤患者血清AFP,CEA,CA19-9和CA125的变化及临床意义[J].第四军医大学学报,2006,27(6):518-520. 被引量:12
  • 2赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 3Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study[J]. N Engl J Med, 1993,328(19):1365-1371.
  • 4Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood[J]. J Natl Cancer Inst, 1999,91 (5) : 434-437.
  • 5Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult blood screening for colorectal cancer[J]. Lancet, 1996,348(9040): 1472-1477.
  • 6Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for coloreetal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds[J]. Gut, 2002, 50(1):29-32.
  • 7Hehn J,Choi J,Sutphen R,et al.Current and evolving strategies for colorectal cancer screening [J]. Cancer Control, 2003,10(3): 193-204.
  • 8Young GP, St John D J, Winawer S J, et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report [J]. Am J Gastroenterol,2007,97(10):2499-2507.
  • 9Stegeman I, de Wijkerslooth TR, Mallant-Hent RC, et al. Implementation of population screening for eolorectal cancer by repeated Fecal Immunochemical Test (FIT): third round [J].BMC Gastroenterol,2012,12:73.
  • 10Sohn DK, Jeong SY, Choi HS, et al.Single immunochemical fecal occult blood test for detection of colorectal neoplasia [J]. Cancer Res Treat,2005,37:20-23.

共引文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部